Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 9196574

Interferon beta: the current position.

B R Boothman
View original source ↗Export metadata ↓

Abstract

Treatments that reduce disease activity in multiple sclerosis are now available, but it is not known how these agents will modify the development of disability in the long term. Published trials of the use of interferon beta failed to detect any clinically relevant reduction in accumulation of disability during the study period. Should patients therefore be prescribed these compounds?

Explore related subjects

Antibody FormationClinical Trials as TopicDose-Response Relationship, DrugEvidence-Based MedicineHumansInterferon-betaMultiple SclerosisTreatment OutcomeJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B R Boothman. Interferon beta: the current position.. https://pubmed.ncbi.nlm.nih.gov/9196574/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Gene silencing results in instability of antibody production in transgenic plants.

The stability of antibody and Fab expression was assessed in five different homozygous transgenic Arabidopsis lines. Each of these lines showed silencing of the transgenes that encode the antibody polypeptides, leading to instability of antibody production. However, each line had a different and specific instability profile. The characteristic variation in the level of antibody accumulation in each line as a function of developmental stage indicated that the T-DNA integration pattern played a role in triggering silencing, and also that the history and the integration position of simple transgene loci can influence the susceptibility to epigenetic silencing. In different lines with low antibody accumulation levels, methylation was found either in the promoter alone, in both the promoter and the transcribed region, in the transcribed region only, or in the transcribed region and downstream sequences. In conclusion, our data suggest that epigenetic effects result in different transgene expression profiles in each of the five Arabidopsis lines analyzed.

Antibody Formation↗